Purpose: The pathophysiology, diagnosis, complications, and management of gestational diabetes mellitus (GDM) are discussed, along with considerations in setting up a pharmacist-run GDM education ...
Cathy created the DeVon Antonio Staton or DAS Foundation Inc. On March 9, 2025, the nonprofit organization will award three ...
People with type 2 diabetes who were given ketones before exercise had increased cardiac output, stroke volume, and ...
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma ...
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control ...
Imagine juggling work and pregnancy at the same time — women can pull off anything, right? While we cheer you on, there’s an ...
7h
Interesting Engineering on MSNFDA approves first-ever rapid-acting insulin biosimilar for diabetes treatmentFirst-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...
A 65-year-old man presented to the ED with 1 day of acute onset mid-thoracic and low back pain, difficulty ambulating and ...
The use of digital twins with industrial, manufacturing and architectural use cases is well known, and in the manifold ...
Primary Biliary Cholangitis Clinical Trial Pipeline 20+ Companies Pioneering The Future Of Treatment
Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...
Health and Me on MSN6d
GLP-1 Drugs Could Be Used To Treat Chronic Kidney DiseaseA latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results